Has Melody Stone, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,275,170 in general payments to Melody Stone, MD across 1,446 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Melody Stone, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Melody Stone, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Melody Stone, MD

Dermatology · Saint Joseph, MONPI 1558337196

Payments from drug & device makers

$4,275,170in general payments, 2019–2025

Across 1,446 payments — averaging $2956.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$843K
AbbVie$612K
Eli Lilly$536K
Incyte Corporation$493K
Pfizer$392K
Janssen Research & Development, LLC$274K
plus $1.1M from 37 others

$18,391in research payments, 2019–2025

Across 6 payments — averaging $3065.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$15K
Bausch Health US, LLC$3K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	29	$843,133
AbbVie(2 entities)	228	$612,109
Eli Lilly	34	$536,199
Incyte Corporation	393	$493,012
Pfizer(2 entities)	188	$392,164
Janssen Research & Development, LLC	72	$274,250
Aclaris Therapeutics, Inc.	25	$254,844
Amgen(2 entities)	33	$168,367
E.r. Squibb & Sons, L.L.C.	28	$80,795
Sanofi US Services Inc.	16	$73,440
Arcutis Biotherapeutics, Inc.	26	$72,035
LEO Pharma AS	20	$57,044
Vanda Pharmaceuticals Inc.	15	$49,517
Journey Medical Corporation	8	$45,963
Regeneron	20	$39,935
Perrigo Company PLC	3	$39,515
Daiichi Sankyo Company LTD	9	$37,933
Padagis US LLC	2	$29,760
Galderma Laboratories, L.p.	19	$27,917
Sun Pharmaceutical Industries Inc.	57	$22,905
Boehringer Ingelheim International GmbH	12	$21,649
Taro Pharmaceuticals USA, Inc.	4	$21,300
Sanofi Pasteur Inc.	5	$20,514
Dr.reddy's Laboratories,inc.	6	$18,250
Daiichi Sankyo Inc.	75	$15,490
VYNE Pharmaceuticals Inc.	11	$9,692
Dermira, Inc.	2	$8,197
Bausch Health US, LLC	2	$5,000
LEO Pharma Inc.	9	$2,513
Johnson & Johnson(2 entities)	30	$536
UCB, Inc.	13	$252
Lilly USA, LLC	10	$182
Sanofi	9	$174
Regeneron Healthcare Solutions, Inc.	7	$140
Genentech USA, Inc.	11	$104
Mayne Pharma Commercial LLC	3	$93
DUSA Pharmaceuticals, Inc.	3	$55
Bristol Myers Squibb	1	$44
Janssen Scientific Affairs, LLC	1	$42
Dermavant Sciences, Inc.	2	$34
Organogenesis Inc.	2	$33
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$20
Prugen, Inc. Pharmaceuticals	2	$16

How this compares

$4,275,170 in reported general payments places this provider in the 95th percentile of 263 dermatology providers in Missouri.

See all dermatology providers in Missouri →

Medicare billing

Part B allowed, 2024

$788,058

Medicare patients

1,334

Services billed

7,846

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Saint Joseph

Milan AnadkatSaint Louis$2.4M
Brian KimSaint Louis$2.3M
Elaine SiegfriedSaint Louis$2.2M
Craig LeonardiSaint Louis$1.7M
David CleaverKirksville$789K
Amy MusiekSaint Louis$577K
Ann MartinSaint Louis$512K
Jonathan CleaverKirksville$483K
Mary GeorgeSaint Louis$400K
Christy RaineyBranson$328K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →